Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,3-Butanediol SCHEMBL16819072 | 0.94 | TDP1 (0.56) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,3-Butanediol SCHEMBL1415145 | 0.94 | TDP1 (0.44) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,3-Butanediol SCHEMBL8093341 | 0.94 | TDP1 (0.44) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,6-Hexanediol SCHEMBL2190350 | 0.91 | TSHR (0.43) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,5-Pentanediol SCHEMBL6423642 | 0.91 | TSHR (0.43) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,3-Butanediol SCHEMBL28244301 | 0.91 | TSHR (0.43) | TDP1TSHRTHRBALDH1A1SMN1; SMN2 | |
| 1,3-Butanediol SCHEMBL222874 | 0.90 | — | — | |
| 1,3-Butanediol SCHEMBL227565 | 0.90 | — | — | |
| 1,3-Butanediol SCHEMBL3427715 | 0.90 | TDP1 (0.53) | TDP1TSHRTHRBALDH1A1ALOX15 | |
| 1,3-Butanediol SCHEMBL8176 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10378029-B2 | Method of producing chemical substance | TORAY INDUSTRIES, INC. (JP) | 2019-08-13 | — | — | US | claimed |
| US-5102953-A | Polysiloxaneurethane copolymer and polyvinyl chloride blends | NIPPON POLURETHANE INDUSTRY CO., LTD. (JP) | 1992-04-07 | — | — | US | claimed |
| CN-118304876-A | Catalyst for producing ethylenically unsaturated carboxylic acid or carboxylic ester and production method | 三菱化学英国有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-111344059-B | Catalyst for producing ethylenically unsaturated carboxylic acid or carboxylic ester and production method | 三菱化学英国有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20240075086-A1 | Dermatological Product | SYMRISE AG (DE) | 2024-03-07 | — | — | US | disclosed |
| US-11786570-B2 | Dermatological product | SYMRISE AG (DE) | 2023-10-17 | — | — | US | disclosed |
| EP-4141044-A1 | BIO-BASED HOT MELT TACKIFIER | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-20210290707-A1 | Dermatological Product | SYMRISE AG (DE) | 2021-09-23 | — | — | US | disclosed |
| EP-2890744-B1 | FLAME-RETARDANT BENZOXAZINE-CONTAINING COMPOSITION | HENKEL AG & CO KGAA (DE) | 2021-02-17 | — | — | EP | disclosed |
| US-20190077972-A1 | Anti-smudge and Anti-graffiti Compositions | HU, HENG (CA) | 2019-03-14 | — | — | US | disclosed |
| US-9428679-B2 | Flame-retardant benzoxazine-containing composition | HENKEL AG & CO. KGAA (DE) | 2016-08-30 | — | — | US | disclosed |
| US-6786956-B2 | INK HAVING THEREIN MIXTURE OF PHOSPHORIC ACID ESTER HAVING ACID NUMBER OF 90 TO 600 AND WEAKLY CATIONIC COMPONENT SELECTED FROM IMIDAZOLINE-TYPE ACTIVATOR, POLYOXYETHYLENE ALKYAMINE, POLYOXYETHYLENE ALKYLAMIDE, ALKYLALKANOLAMIDE | MITSUBISHI PENCIL CO., LTD. (JP) | 2004-09-07 | — | — | US | disclosed |
| US-20020139280-A1 | Ballpoint pen oil-based ink composition and ballpoint pens | MITSUBISHI PENCIL CO., LTD. | 2002-10-03 | — | — | US | disclosed |
| US-20020098437-A1 | Binder-type carrier and two-component developer utilizing the carrier | MINOLTA CO., LTD. (JP) | 2002-07-25 | — | — | US | disclosed |
| EP-0252425-B1 | LOW MELTING URETHANE LINKED TOLUENEDIISOCYANATES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-10-07 | — | — | EP | disclosed |
| EP-0081993-B1 | OPTICALLY ACTIVE ALPHA-SUBSTITUTED ARYL KETONES, THEIR PREPARATION AND THEIR USE IN PREPARING ALPHA-ARYLALKANOIC ACIDS | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1988-08-17 | — | — | EP | disclosed |
| EP-0252425-A2 | Low melting urethane linked toluenediisocyanates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1988-01-13 | — | — | EP | disclosed |
| EP-0248195-A2 | Process for producing aluminum alkoxide or aluminum aryloxide | International Business Machines Corporation (US) | 1987-12-09 | — | — | EP | disclosed |
| US-4683279-A | REACTION WITH DIOL | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1987-07-28 | — | — | US | disclosed |
| EP-0081993-A2 | Optically active alpha-substituted aryl ketones, their preparation and their use in preparing alpha-arylalkanoic acids | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1983-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210290707-A1 | Dermatological Product | DPM1, FUT5, NAMPT | TDP1 1934/4885TSHR 3115/4885THRB 1809/4885 |
| US-11786570-B2 | Dermatological product | DPM1, FUT5, NAMPT | TDP1 1934/4885TSHR 3115/4885THRB 1809/4885 |
| US-20240075086-A1 | Dermatological Product | DPM1, FUT5, NAMPT | TDP1 1934/4885TSHR 3115/4885THRB 1809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.